Carcinogen 4-Nitroquinoline Oxide (4-NQO) Induces Oncostatin-M (OSM) in Esophageal Cells

Background/Aim: The earliest cellular and molecular biologic changes in the esophagus that lead to esophageal cancer were evaluated in a mouse model. We correlated numbers of senescent cells with the levels of expression of potentially carcinogenic genes in sorted side population (SP) cells containing esophageal stem cells and non-stem cells in the non-side population cells in the 4-nitroquinolone oxide (NQO)-treated esophagus. Materials and Methods: We compared stem cells with non-stem cells from the esophagus of mice treated with the chemical carcinogen 4-NQO (100 μg/ml) in drinking water. We also compared gene expression in human esophagus samples treated with 4-NQO (100 μg/ml media) to non-treated samples. We separated and quantitated the relative levels of expression of RNA using RNAseq analysis. We identified senescent cells by luciferase imaging of p16+/LUC mice and senescent cells in excised esophagus from tdTOMp16+ mice. Results: A significant increase in the levels of RNA for oncostatin-M was found in senescent cells of the esophagus from 4-NQO-treated mice and human esophagus in vitro. Conclusion: Induction of OSM in chemically-induced esophageal cancer in mice correlates with the appearance of senescent cells.

[1]  Hong Wang,et al.  Ionizing irradiation-induced Fgr in senescent cells mediates fibrosis , 2021, Cell Death Discovery.

[2]  S. Teichmann,et al.  Molecular phenotyping reveals the identity of Barrett’s esophagus and its malignant transition , 2021, Science.

[3]  A. Rustgi,et al.  Stem cells and origins of cancer in the upper gastrointestinal tract. , 2021, Cell stem cell.

[4]  Hong Wang,et al.  Radiation-Induced Senescence in p16+/LUC Mouse Lung Compared to Bone Marrow Multilineage Hematopoietic Progenitor Cells , 2021, Radiation Research.

[5]  S. Nomura,et al.  Reactivation of the Hedgehog pathway in esophageal progenitors turns on an embryonic-like program to initiate columnar metaplasia. , 2021, Cell stem cell.

[6]  A. Jemal,et al.  Cancer Statistics, 2021 , 2021, CA: a cancer journal for clinicians.

[7]  A. Zekiy,et al.  Oncostatin M: A mysterious cytokine in cancers. , 2020, International immunopharmacology.

[8]  J. Luke,et al.  Molecular correlates and therapeutic targets in T cell-inflamed versus non-T cell-inflamed tumors across cancer types , 2020, Genome Medicine.

[9]  S. Killcoyne,et al.  Aneuploidy in targeted endoscopic biopsies outperforms other tissue biomarkers in the prediction of histologic progression of Barrett's oesophagus: A multi-centre prospective cohort study , 2020, EBioMedicine.

[10]  J. Luke,et al.  Molecular correlates and therapeutic targets in T cell-inflamed versus non-T cell-inflamed tumors across cancer types , 2019, Genome Medicine.

[11]  T. Godfrey,et al.  The Molecular Biologic Basis of Esophageal and Gastric Cancers. , 2019, The Surgical clinics of North America.

[12]  Zhendan He,et al.  Gypenoside L Inhibits Proliferation of Liver and Esophageal Cancer Cells by Inducing Senescence , 2019, Molecules.

[13]  A. Rosemurgy,et al.  The Evolving Landscape of Esophageal Cancer: A Four-Decade Analysis. , 2015, The American surgeon.

[14]  Nicolas Patel,et al.  Incidence of Esophageal Cancer in the United States from 2001-2015: A United States Cancer Statistics Analysis of 50 States , 2018, Cureus.

[15]  R. Wu,et al.  Progress in characterizing the linkage between Fusobacterium nucleatum and gastrointestinal cancer , 2018, Journal of Gastroenterology.

[16]  Nicholas D. Camarda,et al.  Detection of Mutations in Barrett's Esophagus Before Progression to High-Grade Dysplasia or Adenocarcinoma. , 2018, Gastroenterology.

[17]  S. Melov,et al.  Unmasking Transcriptional Heterogeneity in Senescent Cells , 2017, Current Biology.

[18]  H. Kafil,et al.  Carcinogenesis mechanisms of Fusobacterium nucleatum. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[19]  Benjamin J. Raphael,et al.  Integrated genomic characterization of oesophageal carcinoma , 2017, Nature.

[20]  Hong Wang,et al.  Evolution of malignant plasmacytoma cell lines from K14E7 Fancd2−/− mouse long-term bone marrow cultures , 2016, Oncotarget.

[21]  Lior Pachter,et al.  Near-optimal probabilistic RNA-seq quantification , 2016, Nature Biotechnology.

[22]  M. Robinson,et al.  Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences , 2015, F1000Research.

[23]  S. Ishaq,et al.  Helicobacter pylori and gastric cancer: a state of the art review , 2015, Gastroenterology and hepatology from bed to bench.

[24]  Koichi Hirata,et al.  Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis , 2015, Oncotarget.

[25]  Hong Wang,et al.  Esophageal radioprotection by swallowed JP4-039/F15 in thoracic-irradiated mice with transgenic lung tumors. , 2014, In vivo.

[26]  P. Lambert,et al.  High incidence of female reproductive tract cancers in FA deficient HPV16 transgenic mice correlates with E7's induction of DNA damage response, an activity mediated by E7's inactivation of pocket proteins , 2013, Oncogene.

[27]  Charity W. Law,et al.  voom: precision weights unlock linear model analysis tools for RNA-seq read counts , 2014, Genome Biology.

[28]  M. Rugge,et al.  Oxidative DNA Damage in Barrett Mucosa: Correlation with Telomeric Dysfunction and p53 Mutation , 2013, Annals of Surgical Oncology.

[29]  Kenneth K Wang,et al.  The Role of Cellular Senescence in the Gastrointestinal Mucosa , 2013, Gut and liver.

[30]  T. Godfrey,et al.  Gene expression profiles in esophageal adenocarcinoma predict survival after resection. , 2013, The Journal of thoracic and cardiovascular surgery.

[31]  J. Luketich,et al.  Oesophageal carcinoma , 2013, The Lancet.

[32]  Ghulam Abbas,et al.  Outcomes After Minimally Invasive Esophagectomy: Review of Over 1000 Patients , 2012, Annals of surgery.

[33]  J. Flickinger,et al.  Retrospective Review of Patients With Locally Advanced Esophageal Cancer Treated at the University of Pittsburgh , 2011, American journal of clinical oncology.

[34]  Hong Wang,et al.  Amelioration of radiation esophagitis by orally administered p53/Mdm2/Mdm4 inhibitor (BEB55) or GS-nitroxide. , 2011, In vivo.

[35]  Hong Wang,et al.  Role of the esophageal vagus neural pathway in ionizing irradiation-induced seizures in nitric oxide synthase-1 homologous recombinant negative NOS1-/- mice. , 2011, In vivo.

[36]  E. Oki,et al.  Loss of p53 in esophageal squamous cell carcinoma and the correlation with survival: Analyses of gene mutations, protein expression, and loss of heterozygosity in Japanese patients , 2011, Journal of surgical oncology.

[37]  J. Luketich,et al.  A phase I study of concurrent chemotherapy (paclitaxel and carboplatin) and thoracic radiotherapy with swallowed manganese superoxide dismutase plasmid liposome protection in patients with locally advanced stage III non-small-cell lung cancer. , 2010, Human gene therapy.

[38]  S. Duensing,et al.  Deficiencies in the Fanconi anemia DNA damage response pathway increase sensitivity to HPV-associated head and neck cancer. , 2010, Cancer research.

[39]  P. Thongsuksai,et al.  Specific intronic p53 mutation in esophageal squamous cell carcinoma in Southern Thailand. , 2010, World journal of gastroenterology.

[40]  Hong Wang,et al.  Intraesophageal administration of GS-nitroxide (JP4-039) protects against ionizing irradiation-induced esophagitis. , 2010, In vivo.

[41]  Hong Wang,et al.  Intraesophageal Manganese Superoxide Dismutase-Plasmid Liposomes Ameliorates Novel Total-Body and Thoracic Radiation Sensitivity of NOS1−/− Mice , 2010, Radiation research.

[42]  A. Casson,et al.  Dietary folate and vitamin B6 are not associated with p53 mutations in esophageal adenocarcinoma , 2010, Molecular carcinogenesis.

[43]  Hong Wang,et al.  Irradiated Esophageal Cells are Protected from Radiation-Induced Recombination by MnSOD Gene Therapy , 2010, Radiation research.

[44]  A. Krasinskas,et al.  Esophagectomy for T1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy. , 2009, The Annals of thoracic surgery.

[45]  I. König,et al.  p53 Mutations in Carcinoma of the Esophagus and Gastroesophageal Junction , 2009, Cancer investigation.

[46]  P. Hainaut,et al.  Inducible nitric oxide synthase, nitrotyrosine and p53 mutations in the molecular pathogenesis of Barrett's esophagus and esophageal adenocarcinoma , 2008, Molecular carcinogenesis.

[47]  Hao Wang,et al.  Intraesophageal MnSOD-plasmid liposome enhances engraftment and self-renewal of bone marrow derived progenitors of esophageal squamous epithelium , 2008, Gene Therapy.

[48]  J. Luketich,et al.  Photodynamic Therapy with Curative Intent for Barrett’s Esophagus with High Grade Dysplasia and Superficial Esophageal Cancer , 2007, Annals of Surgical Oncology.

[49]  A. Klein-Szanto,et al.  AKT induces senescence in primary esophageal epithelial cells but is permissive for differentiation as revealed in organotypic culture , 2007, Oncogene.

[50]  Michael Epperly,et al.  Protection of esophageal multi-lineage progenitors of squamous epithelium (stem cells) from ionizing irradiation by manganese superoxide dismutase-plasmid/liposome (MnSOD-PL) gene therapy. , 2005, In vivo.

[51]  Li-Ya Li,et al.  Mutations of p53 gene exons 4-8 in human esophageal cancer. , 2005, World journal of gastroenterology.

[52]  J. Luketich,et al.  Photodynamic therapy induced esophageal stricture--an animal model: from mouse to pig. , 2005, Journal of Surgical Research.

[53]  J. Greenberger,et al.  In vitro differentiation capacity of esophageal progenitor cells with capacity for homing and repopulation of the ionizing irradiation-damaged esophagus. , 2004, In vivo.

[54]  O. Kocher,et al.  Evaluation of p53 mutations in premalignant esophageal lesions and esophageal adenocarcinoma using laser capture microdissection , 2004, Modern Pathology.

[55]  J. Greenberger,et al.  Bone Marrow Origin of Cells with Capacity for Homing and Differentiation to Esophageal Squamous Epithelium , 2004, Radiation research.

[56]  Alex G. Little,et al.  Obesity Correlates with Gastroesophageal Reflux , 1999, Digestive Diseases and Sciences.

[57]  James S. McCaughan,et al.  Minimally Invasive Esophagectomy: Outcomes in 222 Patients , 2003, Annals of surgery.

[58]  T. Yamaguchi,et al.  K-ras codon 12 mutations of the super-minute dysplasia in Barrett's esophagus by DNA extraction using a microdissection method. , 2003, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[59]  R. Sutton,et al.  TP53 mutations in malignant and premalignant Barrett's esophagus. , 2003, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[60]  J. Greenberger,et al.  Radioprotection of lung and esophagus by overexpression of the human manganese superoxide dismutase transgene. , 2002, Military medicine.

[61]  W. Keith,et al.  'Senescence-associated' beta-galactosidase activity in the upper gastrointestinal tract. , 2002, The Journal of pathology.

[62]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[63]  D. Bar-Sagi,et al.  Manganese superoxide dismutase‐plasmid/liposome (MnSOD‐PL) administration protects mice from esophagitis associated with fractionated radiation , 2001, International journal of cancer.

[64]  D. Liggitt,et al.  Modulation of Radiation-Induced Cytokine Elevation Associated with Esophagitis and Esophageal Stricture by Manganese Superoxide Dismutase-Plasmid/Liposome (SOD2-PL) Gene Therapy , 2001, Radiation research.

[65]  J. Luketich,et al.  Plasmid/liposome transfer of the human manganese superoxide dismutase transgene prevents ionizing irradiation‐induced apoptosis in human esophagus organ explant culture , 2000, International journal of cancer.

[66]  J. Greenberger,et al.  Prevention of irradiation-induced esophagitis by plasmid/liposome delivery of the human manganese superoxide dismutase transgene. , 1999, Radiation oncology investigations.

[67]  T. Demeester,et al.  Barrett's esophagus. The significance of p53 in clinical practice. , 1997, Annals of surgery.

[68]  M. Inomata,et al.  Prognostic significance of the p53 mutation in esophageal cancer. , 1996, Japanese journal of clinical oncology.

[69]  C. Férec,et al.  Molecular analysis of the TP53 gene in Barrett's adenocarcinoma , 1996, Human mutation.

[70]  H. Yamasaki,et al.  High frequency of ki‐ras amplification and p53 gene mutations in adenocarcinomas of the human esophagus , 1995, Molecular carcinogenesis.

[71]  N. Shepherd,et al.  Adenocarcinoma arising in Barrett's oesophagus: evidence for the participation of p53 dysfunction in the dysplasia/carcinoma sequence. , 1994, Gut.

[72]  J. Roth,et al.  p53 gene mutations in Barrett's epithelium and esophageal cancer. , 1991, Cancer research.

[73]  R Montesano,et al.  Frequent mutation of the p53 gene in human esophageal cancer. , 1990, Proceedings of the National Academy of Sciences of the United States of America.